O

Odimma Therapeutics

8 employees

Odimma is a biotech company that focuses on precision medicine and cure for personalized cancer immunotherapy.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Life Science
Therapeutics
Cancer Immunotherapy
DeepTech
Onco-Immunology
Research & Development
Health Care
Personalized Medicine

Date founded

2017

Funding rounds raised

Total raised

$2M

from 2 investors over 2 rounds

O

Odimma Therapeutics raised $2M on April 13, 2023

Investors: Angels Santé and Alsace Business Angels

FAQ